Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This innovative compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
As a research chemical, tirzepatide (LY3298176) exhibits greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity. This unique dual mechanism has shown promising results in preclinical studies for metabolic research applications.
Our facility produces pharmaceutical-grade tirzepatide with purity exceeding 99.5%. The white powder is carefully packaged to maintain stability and is suitable for various research applications. We offer flexible customization options including different vial sizes (from 2mg to 60mg) and packaging configurations to meet specific research requirements.
For researchers looking to buy tirzepatide, we provide comprehensive quality documentation including Certificates of Analysis. Each batch undergoes rigorous testing to ensure consistency and purity for research purposes. Our production follows strict quality control protocols to deliver reliable research materials.
Note: This product is intended for research use only. Not for human consumption. Researchers should handle all materials according to appropriate laboratory safety protocols.